Human arginase I (HARGI) is a metalloprotein highly expressed
in
the liver cytosol and catalyzes the hydrolysis of
l
-arginine
to form
l
-ornithine and urea. Understanding the reaction
mechanism would be highly helpful to design new inhibitor molecules
for HARGI as it is a target for heart- and blood-related diseases.
In this study, we explored the hydrolysis reaction mechanism of HARGI
with antiferromagnetic and ferromagnetic coupling between two Mn(II)
ions at the catalytic site by employing molecular dynamics simulations
coupled with quantum mechanics and molecular mechanics (QM/MM). The
spin states, high-spin ferromagnetic couple (
S
Mn1
= 5/2,
S
Mn2
= 5/2), low-spin
ferromagnetic couple (
S
Mn1
= 1/2,
S
Mn2
= 1/2), high-spin antiferromagnetic couple
(
S
Mn1
= 5/2,
S
Mn2
= −5/2), and low-spin antiferromagnetic couple (
S
Mn1
= 1/2,
S
Mn2
= −1/2)
are considered, and the calculated energetics for the complex of the
substrate and HARGI are compared. The results show that the high-spin
antiferromagnetic couple (
S
Mn1
= 5/2,
S
Mn2
= −5/2) is more stable than other
spin states. The low-spin ferromagnetic and antiferromagnetic coupled
states are highly unstable compared with the corresponding high-spin
states. The high-spin antiferromagnetic couple (
S
Mn1
= 5/2,
S
Mn2
= −5/2)
is stabilized by 0.39 kcal/mol compared with the ferromagnetic couple
(
S
Mn1
= 5/2,
S
Mn2
= 5/2). The reaction mechanism is independent of spin states; however,
the energetics of transition states and intermediates are more stable
in the case of the high-spin antiferromagnetic couple (
S
Mn1
= 5/2,
S
Mn2
= −5/2)
than the corresponding ferromagnetic state. It is evident that the
calculated coupling constants are higher for antiferromagnetic states
and, interestingly, superexchange coupling is found to occur between
Mn(II) ions via hydroxide ions in a reactant. The hydroxide ion enhances
the coupling interaction and initiates the catalytic reaction. It
is also noted that the first intermediate structure where there is
no superexchange coupling is similar to the known inhibitor 2(
S
)-amino-6-boronohexanoic acid.